Biotech · Private company
Biojiva LLC
Track this companyFree. Adds Biojiva LLC to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- RT001Phase 3 · Friedreich's AtaxiaClinicalTrials.gov · fetched Nov 12, 2026
- RT001Phase 3 · Infantile Neuroaxonal DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- BRX011Phase 2 · Geographic AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- High dose cohortPhase 2 · Friedreich's AtaxiaClinicalTrials.gov · fetched Nov 12, 2026
- Low dose cohortPhase 2 · Friedreich's AtaxiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular DegenerationPHASE1_PHASE2 · RECRUITING · started Sep 29, 2026ClinicalTrials.gov NCT07029945 · fetched Nov 12, 2026
- A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's AtaxiaPHASE3 · COMPLETED · started Oct 30, 2019ClinicalTrials.gov NCT04102501 · fetched Nov 12, 2026
- A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal DystrophyPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Nov 5, 2018ClinicalTrials.gov NCT03570931 · fetched Nov 12, 2026
- Natural History of Infantile Neuroaxonal DystrophyCOMPLETED · started Jul 30, 2018ClinicalTrials.gov NCT03999814 · fetched Nov 12, 2026
- A First in Human Study of RT001 in Patients With Friedreich's AtaxiaPHASE1_PHASE2 · COMPLETED · started Aug 1, 2015ClinicalTrials.gov NCT02445794 · fetched Nov 12, 2026